Reproductive Health & Justice FOIA Request Seeks Deeper Dive into Mifepristone Safety Data from FDA April 9, 2026 Rifan Muazin A Freedom of Information Act (FOIA) request has been submitted to the U.S. Food and Drug Administration (FDA) seeking comprehensive safety data related to mifepristone, a medication used in medication…
Reproductive Health & Justice Federal Lawmakers Move to Ban Mifepristone Amidst Growing Reproductive Rights Challenges Across the U.S. April 8, 2026 Rifan Muazin The landscape of reproductive rights in the United States is undergoing a significant and often contentious transformation, marked by federal legislative efforts to restrict access to medication abortion, state-level criminalization…
Reproductive Health & Justice Federal Lawmakers Seek to Ban Mifepristone Amidst Escalating State-Level Reproductive Rights Battles April 1, 2026 Rifan Muazin Federal lawmakers are intensifying their efforts to restrict access to mifepristone, a crucial medication used in medication abortions, while several states are enacting increasingly severe measures that criminalize individuals seeking…
Reproductive Health & Justice Federal Lawmakers Intensify Efforts to Restrict Mifepristone Access Amidst Growing State-Level Abortion Bans and Legal Challenges March 24, 2026 Rifan Muazin Federal lawmakers are intensifying their efforts to restrict access to mifepristone, a key medication used in medication abortions, as a patchwork of state-level abortion bans and legal challenges continues to…
